An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A nurse practitioner named Bracha Banayan has released a new book called "Why Are You Still Hungry?" It's described as a patient guide that explains GLP-1 medications (the class that includes drugs like Ozempic and Wegovy) and focuses on how to combine those medicines with lasting habit change. The announcement comes from PR Newswire, which is a service that shares press releases from authors and companies. GLP-1 medications are a type of drug that mimic a natural hormone in your gut. In plain terms, they help you feel less hungry, make you feel full sooner, and slow how quickly food leaves your stomach. People have been using these drugs for diabetes and, more recently, for weight management. Banayan’s book aims to explain how these medicines work in everyday language and to give patients practical steps for changing habits while on treatment. The release is for a guidebook, not a research study. That means it’s mostly an informational and practical resource based on the author’s clinical experience rather than new clinical trial data. The announcement doesn’t claim the book contains new experimental results or large-scale scientific findings. Instead, it appears designed to help people understand existing medications and how to use them thoughtfully as part of lifestyle change. Why this matters is straightforward: lots of people are hearing about GLP-1 drugs and want clear, trustworthy advice about how they fit into real life. A patient-focused guide by a nurse practitioner could be useful for people considering these medications, those already on them, and healthcare providers who want a simple way to explain things. If the book gives actionable tips for forming habits that last after stopping a medication, that could be especially valuable because weight and appetite often rebound when treatment ends. There are important caveats. A book is not a substitute for medical advice tailored to your situation. GLP-1 drugs have side effects (like nausea or digestive changes) and aren’t right for everyone; they should be prescribed and monitored by a clinician. Also, because this is a press release about a guide, it doesn’t provide new evidence about long-term safety or effectiveness of combining these medications with specific habit-change programs. If you’re thinking about starting or stopping a medication, talk with your healthcare provider about risks, benefits and alternatives. Bottom line: this looks like a practical, clinician-written guide to help patients understand GLP-1 medications and think about lasting behavior changes, but it’s educational rather than a source of new scientific proof.
Source: PR Newswire